Investors should always be on the lookout for insights that could give them an edge in the stock market, and one potential source of such information is insider buying activity. When company insiders, such as executives or board members, buy shares of a company’s stock, it can be seen as a vote of confidence in the company’s prospects. Publicly available insider buying information can provide valuable clues about which stocks may be worth considering for investment.
Here are three stocks recently purchased by C-level insiders –
Societal CDMO, Inc. – SYM: SCTL
Recent Price: $0.47
Insider Action: 9 insiders buy $2.7 mil in shares
Description: Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
This A.I. predicts the future price of TSLA, NVDA, and AAPL
One of the world’s most cutting-edge financial tech companies just launched Project An-E – an A.I.-driven market forecasting system that accurately predicts stock prices one month into the future. For a limited time, you can get a “sneak peek” of some An-E’s predictions, so you can see what it’s capable of for yourself. You could start making sizable gains in as little as a month.
Click here to learn more.
VolitionRx Limited – SYM: VNRX
Recent Price: $1.32
Insider Action: 8 insiders buy $108K in shares
Description: VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge
Marc Lichtenfeld – Author of the best-selling book Get Rich With Dividends – is giving away his Ultimate Dividend Package…
Movano Inc. – SYM: MOVE
Recent Price: $1.10
Insider Action: 5 insiders buy $340K in shares
Description: Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It also develops System-on-a-Chip (SoC), for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.